{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:36Z","timestamp":1791924756578,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clinph.2025.2110989","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:56:08Z","timestamp":1756223768000},"page":"2110989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Electrophysiological findings in immune checkpoint inhibitor-related neuromuscular events"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-717X","authenticated-orcid":false,"given":"E.","family":"Lainez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4655-6157","authenticated-orcid":false,"given":"A.","family":"Llaurad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1983-0659","authenticated-orcid":false,"given":"M.","family":"Gratac\u00f2s-Vi\u00f1ola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-1511","authenticated-orcid":false,"given":"J.L.","family":"Seoane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3365-4521","authenticated-orcid":false,"given":"E.","family":"Trallero-Aragu\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roca-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Juntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9471-9096","authenticated-orcid":false,"given":"N.","family":"Raguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2025.2110989_b0005","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16335","article-title":"Electrodiagnostic subtyping in Guillain-Barr\u00e9 syndrome patients in the International Guillain-Barr\u00e9 Outcome Study","volume":"31","author":"Arends","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"42","key":"10.1016\/j.clinph.2025.2110989_b0010","first-page":"309","article-title":"Myasthenia gravis induced by immune checkpoint inhibitors","volume":"2019","author":"Becquart","year":"1997","journal-title":"J. Immunother. Hagerstown Md."},{"key":"10.1016\/j.clinph.2025.2110989_b0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jns.12371","article-title":"Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: experience beyond the clinical trials","volume":"25","author":"Bruna","year":"2020","journal-title":"J. Peripher. Nerv. Syst. JPNS"},{"key":"10.1016\/j.clinph.2025.2110989_b0020","article-title":"A review of neurotoxicities associated with immunotherapy and a framework for evaluation","volume":"3","author":"Burton","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.clinph.2025.2110989_b0025","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.clinph.2019.03.035","article-title":"Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy","volume":"130","author":"Chen","year":"2019","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.clinph.2025.2110989_b0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neurol.2023.03.003","article-title":"Neurological adverse events of immune checkpoint inhibitors: an update of clinical presentations, diagnosis, and management","volume":"179","author":"Farina","year":"2023","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.clinph.2025.2110989_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1474-4422(23)00369-1","article-title":"Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes","volume":"23","author":"Farina","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinph.2025.2110989_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002890","article-title":"Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors","volume":"9","author":"Guidon","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.clinph.2025.2110989_b0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/annonc\/mdw655","article-title":"Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm","volume":"28","author":"Haddox","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.clinph.2025.2110989_b0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14740338.2020.1738382","article-title":"Neurologic complications of immune checkpoint inhibitors","volume":"19","author":"Haugh","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.clinph.2025.2110989_b0055","doi-asserted-by":"crossref","unstructured":"Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision. J. Peripher. Nerv. Syst. JPNS 2010;15:1\u20139. https:\/\/doi.org\/10.1111\/j.1529-8027.2010.00245.x.","DOI":"10.1111\/j.1529-8027.2010.00245.x"},{"key":"10.1016\/j.clinph.2025.2110989_b0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12883-019-1416-1","article-title":"Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report","volume":"19","author":"Kamo","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clinph.2025.2110989_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120089","article-title":"CNS and PNS manifestation in immune checkpoint inhibitors: a systematic review","volume":"432","author":"Khan","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clinph.2025.2110989_b0070","first-page":"1794","article-title":"Myocarditis, myositis, and myasthenia gravis overlap syndrome associated with immune checkpoint inhibitors: a systematic review","volume":"14","author":"Lipe","year":"2024","journal-title":"Diagn Basel Switz."},{"key":"10.1016\/j.clinph.2025.2110989_b0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.semarthrit.2013.12.005","article-title":"The co-existence of myasthenia gravis in patients with myositis: a case series","volume":"43","author":"Paik","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clinph.2025.2110989_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab220","article-title":"Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae","volume":"3","author":"Pla\u00e7ais","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.clinph.2025.2110989_b0085","first-page":"e19","article-title":"Electromyography and neuromuscular disorders: clinical-electrodiagnostic-ultrasound correlations, Fourth Edition","volume":"38","author":"Preston","year":"2021","journal-title":"J. Clin. Neurophysiol. Off. Publ. Am. Electroencephalogr. Soc."},{"issue":"47","key":"10.1016\/j.clinph.2025.2110989_b0090","article-title":"Neuromuscular complications of immune checkpoint inhibitors","volume":"2018","author":"Psimaras","year":"1983","journal-title":"Presse Medicale Paris Fr."},{"key":"10.1016\/j.clinph.2025.2110989_b0095","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s00415-023-11625-1","article-title":"Peripheral nervous system adverse events associated with immune checkpoint inhibitors","volume":"270","author":"Rossi","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.clinph.2025.2110989_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa181","article-title":"Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy","volume":"2","author":"Shelly","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.clinph.2025.2110989_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mus.24750","article-title":"Reference values for jitter recorded by concentric needle electrodes in healthy controls: a multicenter study","volume":"53","author":"St\u00e5lberg","year":"2016","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.clinph.2025.2110989_b0110","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/acn3.654","article-title":"Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia","volume":"5","author":"Takamatsu","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clinph.2025.2110989_b0115","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.clinph.2005.04.003","article-title":"Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines","volume":"116","author":"Tankisi","year":"2005","journal-title":"Clin. Neurophysiol. off. J. Int. Fed. Clin. Neurophysiol."},{"key":"10.1016\/j.clinph.2025.2110989_b0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","article-title":"Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"29","author":"Van den Bergh","year":"2004","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.clinph.2025.2110989_b0125","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1470-2045(24)00278-X","article-title":"Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study","volume":"25","author":"Wan","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clinph.2025.2110989_b0130","first-page":"501","article-title":"Neurological adverse events related to immune checkpoint inhibitors: a practical review","volume":"17","author":"Zammit","year":"2024","journal-title":"Pharm Basel Switz"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245725008417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245725008417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:56:41Z","timestamp":1762210601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245725008417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"alternative-id":["S1388245725008417"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2025.2110989","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiological findings in immune checkpoint inhibitor-related neuromuscular events","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2025.2110989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"2110989"}}